Renal Autotransplantation; Case Series

Enrolling by invitationOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

September 15, 2024

Study Completion Date

September 30, 2024

Conditions
Renal Vascular DiseaseNutcracker Syndrome, RenalPelvic TraumaLoin Pain-Hematuria SyndromeRenal TumorCongestion, Venous
Interventions
PROCEDURE

Pre-Operative Information

Demographics (e.g., age, gender), patient characteristics (e.g., BMI, American Society of Anesthesiologists class), and pre-operative medical history (e.g., tobacco use; comorbidities: hypertension, cardiopulmonary disease, diabetes; indication for RAT; lesions; previous renal revascularization; serum creatinine level).

PROCEDURE

Intra-Operative Data

Operative time, total OR time, concomitant procedures, transfusions, conversions, intraoperative adverse events, autotransplantation technique

OTHER

Post-Operative Data (up to discharge)

Postoperative adverse events, discharge status, hospital length of stay, information on enhanced recovery program

OTHER

Short-Term Follow-Up Data

Adverse events, re- admissions, re-operations related to the index procedure

Trial Locations (1)

75203

Liver Institute of Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER